HELLO CHINA

INDUSTRY CLUSTER · Biomedicine

Zhongguancun Miyun Life and Health Services Industrial Park

Miyun’s specialized park co-locates medicine and device production with shared platforms and commercialization services, while each company remains bounded by its own licensed products and operating status.

Formation and regional foundations

Zhongguancun Miyun Life and Health Services Industrial Park appears in authority material dated 2026, and each named entity uses its corresponding public record.

The authority material uses the name Zhongguancun Miyun Life and Health Services Industrial Park. A working review can begin with drug candidates and R&D validation.

Core geography: Life-health manufacturing area of Zhongguancun Miyun Park

Zhongguancun Miyun Life and Health Services Industrial Park operating-chain map

Six supply-and-demand connections in Zhongguancun Miyun Life and Health Services Industrial Park

The map for Zhongguancun Miyun Life and Health Services Industrial Park lists inputs, operations, a named entity, outputs, demand and delivery conditions in sequence.

  • drug candidates — Input review for Zhongguancun Miyun Life and Health Services Industrial Park centres on drug candidates and checks material identity, compliance documents, lot and storage or transport conditions before work begins.
  • R&D validation — Operations for Zhongguancun Miyun Life and Health Services Industrial Park follow R&D validation and record controlled steps, validation status, environmental conditions and deviation handling at each handoff.
  • prescription medicines — Output scope for Zhongguancun Miyun Life and Health Services Industrial Park covers prescription medicines, with intended scope, test results, release documents and storage or transport requirements defined separately.
  • hospitals — Demand for Zhongguancun Miyun Life and Health Services Industrial Park comes from hospitals, with specifications and delivery terms checked against research, production, clinical or regulatory use conditions.
  • innovative medicines acceptance criteria — Acceptance for Zhongguancun Miyun Life and Health Services Industrial Park follows innovative medicines acceptance criteria, with measurement and retest results linked to a controlled lot or validated revision.
  • innovative medicines delivery arrangements — Delivery for Zhongguancun Miyun Life and Health Services Industrial Park follows innovative medicines delivery arrangements and checks release status, temperature control, protection, handover and traceability files.

01 · Zhongguancun Miyun Life and Health Services Industrial Park: Inputs and inbound terms

This chapter reviews input mix and inbound conditions for Zhongguancun Miyun Life and Health Services Industrial Park.

Input mix: drug candidates, cell-culture inputs, medical materials, precision parts and registration dossiers.

For the path from drug candidates through R&D validation to prescription medicines, first check material identity, compliance documents, lot and storage or transport conditions, retain practical samples and verify sites, equipment or services through records and field conditions.

In Beijing, physical inputs such as drug candidates carry a lot trail through packaging, transport and traceability records, while sites, equipment or services retain their own reference numbers.

  • Before Zhongguancun Miyun Life and Health Services Industrial Park moves into execution, material identity, compliance documents, lot and storage or transport conditions should be explicit.

02 · Zhongguancun Miyun Life and Health Services Industrial Park: Operations and handoffs

This chapter reviews production stages and engineering interfaces for Zhongguancun Miyun Life and Health Services Industrial Park.

Operating sequence: R&D validation, clean production, device assembly, quality testing, registration and commercialization.

After a change to R&D validation, reassess innovative medicines acceptance criteria and update records for controlled steps, validation status, environmental conditions and deviation handling.

Before R&D validation in Beijing moves to prescription medicines, use a limited trial, test harvest or stage result to confirm the output boundary.

  • Before Zhongguancun Miyun Life and Health Services Industrial Park moves into execution, equipment, software versions and accountable owners should be explicit.

03 · Zhongguancun Miyun Life and Health Services Industrial Park: Outputs and acceptance

This chapter reviews output forms and acceptance measures for Zhongguancun Miyun Life and Health Services Industrial Park.

Output range: prescription medicines, culture and sampling products, emergency devices, imaging aids and technical services.

Acceptance of prescription medicines from R&D validation in Beijing should specify reproducible samples, methods, environments and decision rules.

Review of prescription medicines separately covers registration or filing boundaries, specifications, lot records, storage and transport conditions, and user support.

  • Before Zhongguancun Miyun Life and Health Services Industrial Park moves into execution, specifications, test environments and delivery documents should be explicit.

04 · Zhongguancun Miyun Life and Health Services Industrial Park: Demand and purchasing

This chapter reviews demand side and purchasing routes for Zhongguancun Miyun Life and Health Services Industrial Park.

Demand side: hospitals, testing laboratories, pharmaceutical distributors and research-translation teams.

In Beijing, demand from hospitals can be separated by research, production, clinical or regulatory use conditions, then matched to the conditions for prescription medicines.

An inquiry from hospitals for prescription medicines should state acceptance and delivery terms as well as volume and price.

  • Before Zhongguancun Miyun Life and Health Services Industrial Park moves into execution, use case, volume range and acceptance owner should be explicit.

05 · Zhongguancun Miyun Life and Health Services Industrial Park: Named entities

The three named entities for Zhongguancun Miyun Life and Health Services Industrial Park each link to their own public material.

Youkang Houde Bioproducts Beijing Co., Ltd: The designation report confirms its park-based cell-culture and molecular-diagnostics products.

Fosun Beiling Beijing Medical Technology Co., Ltd: The district designation material lists it as a medical-device operator within the park.

Beijing Kangchen Pharmaceutical Co., Ltd: The district-government field report gives the full legal name and confirms its integrated pharmaceutical research, production and marketing.

  • The three named entities for Zhongguancun Miyun Life and Health Services Industrial Park use only relationships directly stated in their own material.

06 · Zhongguancun Miyun Life and Health Services Industrial Park: Quality and records

This chapter reviews quality review and technical files for Zhongguancun Miyun Life and Health Services Industrial Park.

Check registrations, cleanroom grades, batch release, cold-chain needs and adverse-event responsibilities.

When operating conditions for R&D validation in Beijing change, reassess innovative medicines acceptance criteria and update controlled steps, validation status, environmental conditions and deviation handling.

After release of prescription medicines from R&D validation in Beijing, set retesting, exception isolation and correction deadlines so responsibility remains traceable to a controlled lot or validated revision.

  • Before Zhongguancun Miyun Life and Health Services Industrial Park moves into execution, samples, test conditions and decision rules should be explicit.

07 · Zhongguancun Miyun Life and Health Services Industrial Park: Delivery and site handover

This chapter reviews transport, delivery and site handover for Zhongguancun Miyun Life and Health Services Industrial Park.

Temperature-sensitive products use validated packaging, devices and ambient materials are segregated with lot traceability.

When delivery of prescription medicines from R&D validation in Beijing spans several traceable units or service stages, every deliverable should link back to its record.

Delivery of prescription medicines to hospitals keeps packaging integrity, lot labels, storage temperature, transit time and arrival checks linked.

  • Before Zhongguancun Miyun Life and Health Services Industrial Park moves into execution, packaging, temperature, humidity, shock protection and arrival checks should be explicit.

08 · Zhongguancun Miyun Life and Health Services Industrial Park: Engagement and due diligence

This chapter reviews engagement sequence and due-diligence list for Zhongguancun Miyun Life and Health Services Industrial Park.

Before procurement, review licence holders, production sites, intended use, clinical evidence, recall systems and continuity of supply.

When checking entities including Youkang Houde Bioproducts Beijing Co., Ltd, cluster designation does not prove performance; before quoting prescription medicines, assign responsibility for innovative medicines acceptance criteria and innovative medicines delivery arrangements.

In Life-health manufacturing area of Zhongguancun Miyun Park, an engagement for prescription medicines from R&D validation can begin with a small lot, pilot or stage deliverable before capacity, lead time and longer arrangements are set.

  • Before Zhongguancun Miyun Life and Health Services Industrial Park moves into execution, separate conclusions on regional designation and company capability should be explicit.

Sources and reading notes

Zhongguancun Miyun Life and Health Services Industrial Park follows the name used in the authority material, records the three companies only by complete legal name and directly stated relationship, and leaves capacity, pricing and engagement terms for separate checks.

  • Zhongguancun Miyun Life and Health Services Industrial Park is the cluster name used in the 2026 authority material.
  • The corresponding public record states this relationship for Youkang Houde Bioproducts Beijing Co., Ltd: Zhongguancun Miyun Park | The designation report confirms its park-based cell-culture and molecular-diagnostics products.
  • The corresponding public record states this relationship for Fosun Beiling Beijing Medical Technology Co., Ltd: Miyun Economic Development Zone | The district designation material lists it as a medical-device operator within the park.
  • The corresponding public record states this relationship for Beijing Kangchen Pharmaceutical Co., Ltd: Zhongguancun Miyun Park | The district-government field report gives the full legal name and confirms its integrated pharmaceutical research, production and marketing.

Related companies

These companies have a locally relevant industry role supported by public information. Order is not a ranking, inclusion does not imply authorization, partnership or endorsement, and Hello China does not participate in or guarantee transactions.

A company may request a free correction or removal through the formal channel if its record is inaccurate or it does not wish to be shown. Do not send business licences, authorization letters or other sensitive files through insecure channels.

Sources

Use the original publishers to check dates, scope and definitions; public material is not a transaction guarantee.